
Topical gentamicin 0.1% promotes collagen 7 expression in recessive dystrophic epidermolysis bullosa
Author(s) -
Rahul Mahajan,
Seema Manjunath,
Manoj Gopal Madakshira,
Dipankar De,
Sabia Handa,
Debajyoti Chatterjee,
Bishan Das Radotra
Publication year - 2022
Publication title -
indian dermatology online journal
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2249-5673
pISSN - 2229-5178
DOI - 10.4103/idoj.idoj_554_21
Subject(s) - medicine , gentamicin , epidermolysis bullosa , dermatology , cohort , biopsy , skin biopsy , adverse effect , surgery , antibiotics , genetics , biology
Currently, there is no cure for epidermolysis bullosa (EB) but few studies have explored the role of aminoglycosides in promoting collagen 7 expression in recessive dystrophic EB (RDEB).